Insider Trading activities of Gemphire Therapeutics Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Gemphire Therapeutics Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Gemphire Therapeutics Inc. since year 2005. Table 2 shows the detailed insider transactions of Gemphire Therapeutics Inc. since 2005. The reporting company's ticker symbol is GEMP. The reporting company's CIK number is 1638287.
The total value of stock buying since 2005 is $7,630,436.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $28,296.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Gemphire Therapeutics Inc. (GEMP).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-08 0 $0 0 $0 6,207 $22,283
2017-07 0 $0 0 $0 4,474 $6,013
2017-03 109,476 $1,036,736 0 $0 0 $0
2016-08 659,370 $6,593,700 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Gemphire Therapeutics Inc. insiders (GEMP)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-08-14 Mathiesen Jeffrey S (Chief Financial Officer) Option Ex 3,207 3.59 11,513
2017-08-10 Mathiesen Jeffrey S (Chief Financial Officer) Option Ex 3,000 3.59 10,770
2017-07-31 Bisgaier Charles Phd (Chief Scientific Off. & Chair) Option Ex 4,474 1.34 6,013
2017-03-10 Hawryluk P. Kent (Director) Buy 25,000 9.47 236,750
2017-03-10 Gullans Steven R. Ph.d. (Director) Buy 52,798 9.47 499,997
2017-03-10 Sassine Andy (Director) Buy 21,119 9.47 199,996
2017-03-10 Lichtinger Pedro (Director) Buy 10,559 9.47 99,993
2016-08-10 Lowenschuss David (Chief Legal Off. & Secretary) Buy 11,120 10.00 111,200
2016-08-10 Sooch Mina (President & CEO) Buy 52,500 10.00 525,000
2016-08-10 Reno Seth (Chief Commercial Officer) Buy 4,000 10.00 40,000
2016-08-10 Hawryluk P. Kent (Director) Buy 25,000 10.00 250,000
2016-08-10 Gullans Steven R. Ph.d. (Director) Buy 500,000 10.00 5,000,000
2016-08-10 Lichtinger Pedro (Director) Buy 10,000 10.00 100,000
2016-08-10 Bisgaier Charles Phd (Chair & Chief Scientific Off.) Buy 51,750 10.00 517,500
2016-08-10 Mathiesen Jeffrey S (Chief Financial Officer) Buy 4,000 10.00 40,000
2016-08-10 Kousky Kenneth W (Director) Buy 1,000 10.00 10,000

Insider trading activities including stock purchases, stock sales, and option exercises of GEMP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Gemphire Therapeutics Inc. (symbol GEMP, CIK number 1638287) see the Securities and Exchange Commission (SEC) website.